Drug-induced liver injury in COVID-19 patients during hospitalization

Since coronavirus disease 2019 (COVID-19) outbreaks in December 2019 in Wuhan, almost no studies have systematically described drug-induced liver injury (DILI) in COVID-19 patients. This study aimed to assess the characteristics of liver test abnormality or liver injury in patients with COVID-19, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying, Shi, Cai, Zhan, Haiyan, Yang, Boning, Liu, Jun, Rong, Peipei, Luo, Yi, Yang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018522/
https://www.ncbi.nlm.nih.gov/pubmed/36930097
http://dx.doi.org/10.1097/MD.0000000000033294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018522/
https://www.ncbi.nlm.nih.gov/pubmed/36930097
http://dx.doi.org/10.1097/MD.0000000000033294

Ejemplares similares